These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6160591)

  • 1. Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system.
    Markert ML; Cresswell P
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6101-4. PubMed ID: 6160591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human B cell alloantigens: expression of MB and MT determinants.
    Markert ML; Cresswell P
    J Immunol; 1982 May; 128(5):2004-8. PubMed ID: 6174619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.
    Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological dissection of human Ia molecules.
    Tosi R; Tanigaki N; Centis D; Ferrara GB; Pressman D
    J Exp Med; 1978 Dec; 148(6):1592-611. PubMed ID: 82605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5.
    Karr RW; Kannapell CC; Stein JA; Gebel HM; Mann DL; Duquesnoy RJ; Fuller TC; Rodey GE; Schwartz BD
    J Immunol; 1982 Apr; 128(4):1809-18. PubMed ID: 6174616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human B cell alloantigens; alpha subunit variability.
    Markert ML; Cresswell P
    J Immunol; 1982 May; 128(5):1999-2003. PubMed ID: 6977579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of structural polymorphism among MB3 light chains by two-dimensional gel electrophoresis.
    Ishikawa N; Kasahara M; Ikeda H; Ogasawara K; Hawkin S; Takenouchi T; Wakisaka A; Kikuchi Y; Aizawa M
    J Immunol; 1985 Jan; 134(1):417-22. PubMed ID: 3871113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting.
    Radka SF; Machamer CE; Cresswell P
    Hum Immunol; 1984 Jul; 10(3):177-86. PubMed ID: 6611328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to polymorphic epitopes on Ia antigens: three independent groups of determinants expressed on DRw6 homozygous cells.
    Johnson JP; Wank R
    Eur J Immunol; 1984 Aug; 14(8):739-44. PubMed ID: 6205884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms within the HLA-DR3 haplotypes. I. HLA-DR polymorphisms detected at the protein and DNA levels are reflected by T-cell recognition.
    Bontrop R; Tilanus M; Mikulski M; van Eggermond M; Termijtelen A; Giphart M
    Immunogenetics; 1986; 23(6):401-5. PubMed ID: 3013763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
    Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
    J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The human major histocompatibility complex or HLA complex].
    Lemonnier FA
    Biochimie; 1985 Jan; 67(1):XI-XV. PubMed ID: 2581625
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of class II histocompatibility antigens isolated from a human lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3, 3; B7, 7; Dw2, 2; DR2,2; DC1,1; MB1,1; MT1,1).
    Kratzin H; Yang CY; Götz H; Thinnes FP; Kruse T; Egert G; Pauly E; Kölbel S; Wernet P; Hilschmann N
    Hum Immunol; 1983 Sep; 8(1):65-73. PubMed ID: 6415000
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.
    Shaw S; Johnson AH; Shearer GM
    J Exp Med; 1980 Sep; 152(3):565-80. PubMed ID: 6967946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of B-cell alloantigens: evidence for gene(s) linked to the HLA-A locus.
    Abelson LD; Mann DL
    Tissue Antigens; 1978 Mar; 11(3):295-301. PubMed ID: 77571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines.
    Pollack MS; Livingston PO; Fogh J; Carey TE; Oettgen HF; Dupont B
    Tissue Antigens; 1980 Mar; 15(3):249-56. PubMed ID: 6451045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Ia-like molecules characterize HLA-DR2-associated haplotypes which differ in HLA-D.
    Nepom GT; Nepom BS; Wilson ME; Mickelson E; Antonelli P; Hansen JA
    Hum Immunol; 1984 Jul; 10(3):143-51. PubMed ID: 6430842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes.
    Brodsky FM
    Immunogenetics; 1984; 19(3):179-94. PubMed ID: 6200433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.